Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

Journal of Pathology

Volumn 183, Issue 3, 1997, Pages 311-317

  Dong, Ying ^a   Walsh, Michael D ^a   Cummings, Margaret C ^a   Wright, R Gordon ^a   Khoo, Soo Keat ^a   Parsons, Peter G ^b   McGuckin, Michael A ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Immunohistochemistry; MUC1; MUC2; Mucins; Ovarian carcinoma; Prognosis

Indexed keywords

MUCIN;

ADULT; AGED; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MUCINOUS CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CA-15-3 ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030678460     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2     Document Type: Article

References (34)

1. Devine PL, McKenzie IFC. Mucins: structure, function, and associations with malignancy. Bioessays 1992; 14: 619-625.
2. Gum JR. Mucin genes and the proteins they encode: structure, diversity, and regulation (Review). Am J Respir Cell Mol Biol 1992; 7: 557-564.
3. Gendler SJ, Spicer AP. Epithelial mucin genes (Review). Annu Rev Physiol 1995; 57: 607-634.
4. Zotter S, Hageman PC, Lossnitzer A, Mooi WJ, Higers J. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev 1988; 11: 55-101.
5. Hay FG, Leonard RCF. Expression of human milk fat globule antigens HMFG1 and HMFG2 on ovarian tumours and lung tumours. Dis Markers 1988; 6: 29-39.
6. Girling A, Bartkova J, Burchell J, Gendler S, Gillett N, Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989; 43: 1072-1076.
7. Devine PL, McGuckin MA, Ward BG. Circulating mucins as tumor markers in ovarian cancer (Review). Anticancer Res 1992; 12: 709-717.
8. Xing PX, Reynolds K, Tjandra JJ, Tang ZL, McKenzie IFC. Synthetic peptides reactive with anti-human mild fat globule monoclonal antibodies. Cancer Res 1990; 50: 89-96.
9. Xing PX, Tjandra JJ, Stacker SA, et al. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol 1989; 67: 183-195.
10. McGuckin MA, Wright G, Ward BG. Expression of a polymorphic epithelial mucin antigen defined by the monoclonal antibody BC2 in ovarian carcinoma. Use of the BC2 antibody for the detection of micrometastases. Am J Clin Pathol 1991; 96: 46-52.
11. Devine PL, McGuckin MA, Birrell GW, et al. Second generation monoclonal antibodies reacting with the MUC2 mucin core protein. Br J Cancer 1993; 67: 1182-1188.
12. Jany BH, Gallup MW, Van PS, Gum JR, Kirn YS, Basbaum CB. Human bronchus and intestine express the same mucin gene. J Clin Invest 1991; 87: 77-82.
13. Gerard C, Eddy RL, Shows TB. The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure-evidence for a common mucin in airway and gastro-intestinal tissue. J Clin Invest 1990; 86: 1921-1927.
14. Xing PX, Prezoska J, Layton GT, Devine PL, McKenzie IFC. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst 1992; 84: 699-703.
15. Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Hum Pathol 1994; 25: 364-372.
16. Price MR, Sekowski M, Ladanyi A, et al. Immune recognition of human colonic-tumour-associated MUC-2 mucins using an anti-peptide antibody. Int J Cancer 1993; 55: 753-759.
17. Walsh MD, McGuckin MA, Devine PL, Hohn BG, Wright RG. Expression of MUC2 epithelial mucin in breast carcinoma. J Clin Pathol 1993; 46: 822-925.
18. Walsh MD, Hohn BG, Thong W, Devine PL, Samaratunga MLTH, McGuckin MA. Mucin expression by transitional cell carcinomas of the bladder. Br J Urol 1994; 73: 256-262.
19. Ball NJ, Robertson DI, Duggan MA, Snider DD. Intestinal differentiation in ovarian mucinous tumours. Virchows Arch A [Pathol Anat Histopathol] 1990; 417: 197-201.
20. Tenti P, Aguzzi A, Riva C, et al. Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells. Cancer 1992; 69: 2131-2142.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
22. Croghan GA, Wingate MB, Gamarra M, et al. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Cancer Res 1984; 44: 1954-1962.
23. Ward BG, Lowe DG, Shepherd JG. Patterns of expression of a tumor associated antigen, defined by the monoclonal antibody HMFG2, in human epithelial ovarian carcinoma. Comparison with expression of the HMFG1, AUA1 and F36/22 antigens. Cancer 1987; 60: 787-793.
24. Devine PL, Warren JA, Ward BG, McKenzie IFC, Layton GT. Glycosylation and the exposure of tumour-associated epitopes on mucins. J Tumor Marker Oncol 1990; 11-26.
25. Nishimori I, Perini F, Mountjoy KP, et al. N-Acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts. Cancer Res 1994; 54: 3738-3744.
26. McGuckin MA, Hurst TG, Ward BG. Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma. Int J Cancer 1991; 63: 412-418.
27. Gimmi CD, Morrison BW, Mainprice BA, et al. Breast cancer-associated antigen. DF3/MUC1, induces apoptosis of activated human T cells. Nature Med 1996; 2: 1367-1370.
28. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995; 129: 255-265.
29. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996; 7: 565-577.
30. Hilkens J, Vos HL, Wesseling J, et al. Is episialin/MUC1 involved in breast cancer progression? Cancer Leu 1995; 90: 27-33.
31. van de Wiel-van Kemenade E, Ligtenberg MJL, de Boer AJ, et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993; 151: 767-776.
32. Wreschner DH, Zrihan Licht S, Baruch A, et al. Does a novel form of the breast cancer marker protein. MUC1, act as a receptor molecule that modulates signal transduction? Adv Exp Med Biol 1994; 353: 17-26.
33. Pandey P, Kharbanda S, Kufe D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res 1995; 55: 4000-4003.
34. Van PS, Ho SB, Itzkowitz SH, Byrd JC, Siddiqui B, Kim YS. Expression of native and deglycosylated colon cancer mucin antigens in normal and malignant epithelial tissues. Lab Invest 1990; 63: 698-706.